ScholarIQanswers from OpenAlex

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis

PaperCitations, authors & open-access status

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis have?

ScholarIQcitation count

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis has 57 citations in the OpenAlex counts ScholarIQ stores.

When was Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis published?

ScholarIQyear

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis has 2019 year in the ScholarIQ index.

What is the open-access status of Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis?

ScholarIQoa status

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis has closed oa status in the ScholarIQ index.

What is the DOI of Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis?

ScholarIQdoi

The DOI for Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis is on the source record.

What is the PMID of Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis?

ScholarIQpmid

The PMID for Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis is on the source record.

What is the OpenAlex record for Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis?

ScholarIQopenalex

The OpenAlex for Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial